Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling
- PMID: 19661333
- PMCID: PMC2901158
Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling
Erratum in
- Anticancer Res. 2009 Oct;29(10):4315
Abstract
Background: Curcumin, a natural polyphenol product of the plant Curcuma longa, has been shown to inhibit the growth and progression of colorectal cancer; however, the anticancer mechanism of curcumin remains to be elucidated.
Materials and methods: Colorectal cancer cells were treated with curcumin and changes in proliferation, protein and mRNA levels were analyzed.
Results: Curcumin inhibited proliferation of colorectal cancer cells. This effect was mediated by inhibition of mammalian target of rapamycin (mTOR) signaling as evidenced by decreased phosphorylation of downstream effectors of mTOR complex 1 (mTORC1), p70S6K and 4E-BP1. Curcumin decreased total expression of mTOR, Raptor and Rictor protein and mRNA levels. Surprisingly, curcumin induced phosphorylation of Akt(Ser 473); this effect may be attributed to a decrease in levels of the PHLPP1 phosphatase, an inhibitor of Akt.
Conclusion: Our data suggest that curcumin, a natural compound, may exert its antiproliferative effects by inhibition of mTOR signaling and thus may represent a novel class of mTOR inhibitor.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2901158/bin/nihms148802f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2901158/bin/nihms148802f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2901158/bin/nihms148802f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2901158/bin/nihms148802f4.gif)
Similar articles
-
Curcuma as an adjuvant in colorectal cancer treatment.Life Sci. 2021 Dec 1;286:120043. doi: 10.1016/j.lfs.2021.120043. Epub 2021 Oct 9. Life Sci. 2021. PMID: 34637800 Review.
-
Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.J Cell Physiol. 2018 Jan;233(1):516-529. doi: 10.1002/jcp.25913. Epub 2017 May 3. J Cell Physiol. 2018. PMID: 28300280 Free PMC article.
-
Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer.Cell Death Dis. 2014 Mar 13;5(3):e1114. doi: 10.1038/cddis.2014.43. Cell Death Dis. 2014. PMID: 24625973 Free PMC article.
-
Hitting the golden TORget: curcumin's effects on mTOR signaling.Anticancer Agents Med Chem. 2013 Sep;13(7):988-94. doi: 10.2174/1871520611313070004. Anticancer Agents Med Chem. 2013. PMID: 23272912 Free PMC article. Review.
-
Curcumin disrupts the Mammalian target of rapamycin-raptor complex.Cancer Res. 2009 Feb 1;69(3):1000-8. doi: 10.1158/0008-5472.CAN-08-2367. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176385 Free PMC article.
Cited by
-
The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway.Cancers (Basel). 2024 Apr 18;16(8):1554. doi: 10.3390/cancers16081554. Cancers (Basel). 2024. PMID: 38672636 Free PMC article. Review.
-
Longevity and anti-aging effects of curcumin supplementation.Geroscience. 2024 Jun;46(3):2933-2950. doi: 10.1007/s11357-024-01092-5. Epub 2024 Feb 27. Geroscience. 2024. PMID: 38409646 Free PMC article. Review.
-
Combined Deep Learning and Molecular Modeling Techniques on the Virtual Screening of New mTOR Inhibitors from the Thai Mushroom Database.ACS Omega. 2023 Oct 2;8(41):38373-38385. doi: 10.1021/acsomega.3c04827. eCollection 2023 Oct 17. ACS Omega. 2023. PMID: 37867669 Free PMC article.
-
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder.Molecules. 2023 Feb 16;28(4):1889. doi: 10.3390/molecules28041889. Molecules. 2023. PMID: 36838876 Free PMC article. Review.
-
Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action.Chin Med. 2023 Feb 13;18(1):14. doi: 10.1186/s13020-023-00719-7. Chin Med. 2023. PMID: 36782251 Free PMC article. Review.
References
-
- Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–398. - PubMed
-
- Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269:199–225. - PubMed
-
- Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12:9–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 DK035608/DK/NIDDK NIH HHS/United States
- K01CA10209/CA/NCI NIH HHS/United States
- P01DK35608/DK/NIDDK NIH HHS/United States
- K01 CA102098/CA/NCI NIH HHS/United States
- K01 CA102098-05/CA/NCI NIH HHS/United States
- R01 CA104748/CA/NCI NIH HHS/United States
- R01 CA104748-05/CA/NCI NIH HHS/United States
- R01 DK048498/DK/NIDDK NIH HHS/United States
- P01 DK035608-239004/DK/NIDDK NIH HHS/United States
- P01 DK035608-230001/DK/NIDDK NIH HHS/United States
- R01CA104748/CA/NCI NIH HHS/United States
- R01 DK048498-14/DK/NIDDK NIH HHS/United States
- R01DK48498/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous